These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 37231847

  • 41. Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
    La Vecchia A, Stracquadaino R, Mauri L, Baselli LA, Abdallah R, Cucchetti M, Colli AM, Agostoni C, Dellepiane RM.
    BMC Pediatr; 2024 Feb 23; 24(1):139. PubMed ID: 38395821
    [Abstract] [Full Text] [Related]

  • 42. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 23; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 43. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 23; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 44. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 May 23; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 45. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 46. Association between intravenous immunoglobulin dose and outcomes in patients with acute Kawasaki disease.
    Michihata N, Suzuki T, Yoshikawa T, Saito K, Matsui H, Fushimi K, Yasunaga H.
    Eur J Pediatr; 2022 Oct 19; 181(10):3607-3615. PubMed ID: 35925450
    [Abstract] [Full Text] [Related]

  • 47. Giant aneurysms: A gender-specific complication of Kawasaki disease?
    Dietz SM, Kuipers IM, Tacke CEA, Koole JCD, Hutten BA, Kuijpers TW.
    J Cardiol; 2017 Oct 19; 70(4):359-365. PubMed ID: 28325522
    [Abstract] [Full Text] [Related]

  • 48. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
    Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG.
    Pediatrics; 2019 Jun 19; 143(6):. PubMed ID: 31048414
    [Abstract] [Full Text] [Related]

  • 49. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country.
    Mat Bah MN, Alias EY, Razak H, Sapian MH, Foo FH, Abdullah N.
    Eur J Pediatr; 2021 Aug 19; 180(8):2599-2606. PubMed ID: 34086103
    [Abstract] [Full Text] [Related]

  • 50. A novel scoring system based on sIL-2R for predicting IVIG resistance in Chinese children with KD.
    Zeng YY, Zhu SY, Xu KK, Ji LF, Wang YQ, Chen Y, Chen F, Yang SW.
    Pediatr Rheumatol Online J; 2024 Aug 18; 22(1):76. PubMed ID: 39155376
    [Abstract] [Full Text] [Related]

  • 51. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
    Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
    Pediatr Cardiol; 2017 Feb 18; 38(2):375-380. PubMed ID: 27878631
    [Abstract] [Full Text] [Related]

  • 52. Treatment and Coronary Artery Aneurysm Formation in Kawasaki Disease: A Per-Day Risk Analysis.
    van Stijn D, Korbee JM, Netea SA, de Winter VC, Zwinderman KAH, Kuipers IM, Kuijpers TW.
    J Pediatr; 2022 Apr 18; 243():167-172.e1. PubMed ID: 34968497
    [Abstract] [Full Text] [Related]

  • 53. High risk of coronary artery aneurysm in Kawasaki disease.
    Mossberg M, Mohammad AJ, Kahn F, Segelmark M, Kahn R.
    Rheumatology (Oxford); 2021 Apr 06; 60(4):1910-1914. PubMed ID: 33150451
    [Abstract] [Full Text] [Related]

  • 54. Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.
    Chbeir D, Gaschignard J, Bonnefoy R, Beyler C, Melki I, Faye A, Meinzer U.
    Pediatr Rheumatol Online J; 2018 Jul 18; 16(1):48. PubMed ID: 30021610
    [Abstract] [Full Text] [Related]

  • 55. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
    McCrindle BW, Manlhiot C, Newburger JW, Harahsheh AS, Giglia TM, Dallaire F, Friedman K, Low T, Runeckles K, Mathew M, Mackie AS, Choueiter NF, Jone PN, Kutty S, Yetman AT, Raghuveer G, Pahl E, Norozi K, McHugh KE, Li JS, De Ferranti SD, Dahdah N, International Kawasaki Disease Registry *.
    J Am Heart Assoc; 2020 Aug 04; 9(15):e016440. PubMed ID: 32750313
    [Abstract] [Full Text] [Related]

  • 56. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN, Wu FF, Chang YM, Huang HC, Lin MT, Wang JK, Wu MH.
    J Formos Med Assoc; 2021 Oct 04; 120(10):1884-1889. PubMed ID: 33358267
    [Abstract] [Full Text] [Related]

  • 57. Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.
    Suzuki T, Michihata N, Aso S, Yoshikawa T, Saito K, Matsui H, Fushimi K, Yasunaga H.
    Eur J Pediatr; 2021 Nov 04; 180(11):3279-3286. PubMed ID: 33973071
    [Abstract] [Full Text] [Related]

  • 58. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC.
    Contemp Clin Trials; 2016 May 04; 48():70-5. PubMed ID: 27080929
    [Abstract] [Full Text] [Related]

  • 59. Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease.
    Tai IH, Wu PL, Guo MM, Lee J, Chu CH, Hsieh KS, Kuo HC.
    BMC Pediatr; 2020 May 11; 20(1):203. PubMed ID: 32393306
    [Abstract] [Full Text] [Related]

  • 60. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J, Oh JS, Yoon JM, Ko KO, Yoo GH, Cheon EJ.
    BMC Pediatr; 2022 Aug 05; 22(1):474. PubMed ID: 35931986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.